A S Liamkina

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM To reveal prognostically significant factors affecting efficacy of glivek therapy in untreated (duration of the disease < or = 6 months) and pretreated (duration of the disease > 6 months) patients with chronic myeloid leukemia (CML) in a chronic phase. MATERIAL AND METHODS A total of 338 patients (64 untreated and 274 pretreated) with a chronic-phase(More)
  • 1